Forefront Wealth Partners’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$614K Buy
1,248
+104
+9% +$56.4K 0.26% 86
2025
Q4
$663K Sell
1,144
-243
-18% -$137K 0.31% 70
2025
Q3
$673K Buy
1,387
+480
+53% +$223K 0.17% 106
2025
Q2
$472K Sell
907
-83
-8% -$34.7K 0.32% 62
2025
Q1
$493K Buy
990
+83
+9% +$45K 0.34% 70
2024
Q4
$472K Buy
+907
New +$499K 0.35% 60

Other funds holding TMO

Forefront Wealth Partners's TMO Position: Q1 2026 in Review

Forefront Wealth Partners increased its Thermo Fisher Scientific (TMO) stake by 9.1% in Q1 2026, buying an estimated $56.4K and bringing the position to 1,248 shares worth $614K. The position accounts for 0.26% of the portfolio, ranked #86.

Forefront Wealth Partners first reported a position in TMO in Q4 2024 and has held it in 6 quarters since. The position peaked at $673K in Q3 2025. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Forefront Wealth Partners held 1,248 shares of Thermo Fisher Scientific worth $614K as of Q1 2026.
  • Forefront Wealth Partners bought 104 Thermo Fisher Scientific shares in Q1 2026, an estimated $56.4K.
  • Thermo Fisher Scientific made up 0.26% of Forefront Wealth Partners's portfolio in Q1 2026, its #86 holding.
  • Forefront Wealth Partners first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 6 quarters since.
  • Forefront Wealth Partners's Thermo Fisher Scientific position peaked at $673K in Q3 2025.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Forefront Wealth Partners's 13F filing for Q1 2026, filed 17 Apr 2026.